로그인 회원가입
icon_bulk_order대량 주문 조회 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > CD28

CD28

요약

Name:T-cell-specific surface glycoprotein CD28
Target Synonym:CD28,CD28 Antigen,T-Cell-Specific Surface Glycoprotein CD28,CD28 Antigen (Tp44),Tp44,CD28 Antigens,CD28 Molecule,T-Cell-Specific Surface Glycoprotein
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:13
Lastest Research Phase:Phase 2 Clinical

제품 리스트 비교 또는 구매

일부의 생물활성 데이터

CD8-H525a-SPR
Human_FcRn_Heterodimer_Protein_SPR

Immobilized Human / Cynomolgus / Rhesus macaque CD28, Fc Tag (Cat. No. CD8-H525a) on CM5 Chip can bind Human B7-1, His Tag (Cat. No. B71-H5228) with an affinity constant of 5.29 μM as determined in a SPR assay (Biacore T200) (Routinely tested).

CD8-H525a-SPR
Human_FcRn_Heterodimer_Protein_SPR

Immobilized Human / Cynomolgus / Rhesus macaque CD28, Fc Tag (Cat. No. CD8-H525a) on CM5 Chip can bind Human B7-1, Mouse IgG2a Fc Tag, low endotoxin (Cat. No. B71-H52A4) with an affinity constant of 2.72 μM as determined in a SPR assay (Biacore T200) (Routinely tested).

사용자 리뷰

Synonym Name

CD28,Tp44

Background

T-cell-specific surface glycoprotein CD28 is also known as TP44, is a single-pass type I membrane protein which contains one Ig-like V-type (immunoglobulin-like) domain. is one of the molecules expressed on T cells that provide co-stimulatory signals, which are required for T cell activation. CD28 is the receptor for CD80 (B7.1) and CD86 (B7.2). When activated by Toll-like receptor ligands, the CD80 expression is upregulated in antigen presenting cells (APCs). The CD86 expression on antigen presenting cells is constitutive. CD28 is the only B7 receptor constitutively expressed on naive T cells.

Clinical and Translational Updates

Related Molecule

임상 약품 정보

Name Research Code Research Phase Company Indications Clinical Trials
Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells (City of Hope Medical Center) Phase 1 Clinical City Of Hope National Medical Center Lymphoma, Non-Hodgkin Details
B7-2/GM-CSF cancer gene therapy CIT Phase 1 Clinical Radient Neoplasms Details
InHeAb-01 InHeAb-01; bsAB Clinical Neoplasms Details
CD19 PD-1/CD28 CAR-T Cell Therapy (Second Affiliated Hospital School Of Zhejiang University School Of Medicine) Phase 1 Clinical Second Affiliated Hospital Of Zhejiang University School Of Medicine Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Primary mediastinal B cell lymphoma Details
CC-312 CC-312 Phase 1 Clinical Details
Abatacept (Orban Biotech) Phase 2 Clinical Orban Biotech, The National Institute Of Diabetes And Digestive And Kidney Diseases Diabetes Mellitus, Type 1 Details
Theralizumab TAB-08; TABO-8 Theramab Details
FPT-155 CD80-Fc; FPT-155 Five Prime Therapeutics Inc Details
REGN-5668 REGN-5668 Regeneron Pharmaceuticals Details
REGN-7075 REGN-7075 Regeneron Pharmaceuticals Details
SAR-443216 SAR-443216 Sanofi Details
REGN-5678 REGN-5678 Regeneron Pharmaceuticals Inc Details
Reltecimod P2-TA; AB-103 Atox Bio Details
Davoceticept ALPN-202 Alpine Immune Sciences Details
Acazicolcept ALPN-101 Phase 2 Clinical Alpine Immune Sciences, Abbvie Inc Graft vs Host Disease; Autoimmune Diseases; Lupus Erythematosus, Systemic; Lymphoproliferative Disorders; Inflammation Details
TC-510 TC-510 Phase 2 Clinical Tcr2 Therapeutics Ovarian Neoplasms; Solid tumours; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Mesothelioma; Colorectal Neoplasms; Adenocarcinoma Details
FR-104 FR-104; JNJ-3133; VEL-101 Phase 2 Clinical Effimune Rejection of renal transplantation; Arthritis, Rheumatoid; Postoperative Complications Details
SAR-442257 SAR-442257 Phase 1 Clinical Sanofi Neoplasms Details
Lulizumab pegol Lulizumab; BMS-931699 Phase 2 Clinical Bristol-Myers Squibb Company Lupus Vulgaris; Rejection of renal transplantation; Sjogren-Larsson Syndrome Details

This web search service is supported by Google Inc.

totop